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Background: In modern health services, blood transfusion is an essentially life-saving manoeuvre. With
this situation healthy donor compilation is the cornerstone of transfusion medicine. Henceforth, a
provision for strict criterion in recruitment and deferral of blood donors, particularly emphasizing
transfusion transmissible infections (TTI), may improve safe transfusion practice.
Objectives: The present study was executed to assess the prevalence of TTIs within blood donors at a sub-
Himalayan rural tertiary care institution in Darjeeling, India; which can ultimately aid in determination
of the population subset to be targeted for enhancing donor pool.
Methods: The present study was a three-year (2010e2012) retrospective study. Data was accumulated
and analysed from blood bank records, pertaining to all donors who were screened for various TTIs using
respective immunological methods. Then the tabulated seropositive donors were correlated with rele-
vant epidemiological proﬁles.
Results: Total 28,364 blood donors were examined, comprising of 25,517 (89.96%) males and 20,985
(73.98%) voluntary donors. Cumulative seroprevalence of HIV, HBV, HCV and syphilis were 0.42%, 1.24%,
0.62% and 0.65% respectively; with solitary malaria-infected donor. The overall seroreactivity in present
study signiﬁcantly diminished through successive years.
Conclusions: Deployment of implicit inclusion-exclusion criteria is high on demand for reducing the
prevalence of TTIs, to increase the donor subpopulation strength and ultimately to institute a safe
transfusion protocol.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Transfusion therapy has been the mainstay of several medico-
surgical therapeutics since 1930.1 There are 3 types of blood
donors: voluntary/unpaid, family/replacement, and paid.2 A
voluntary blood donor intentionally donates blood without pur-
suing any remuneration, whereas a replacement donor is requested
to do so by the patient or his associates.3
According to World Health Organization (WHO) Global Data-
base on Blood Safety (GDBS) 2008, total around 91.8 million blood
donations are collected annually. But, approximately 48% of thesendal, Vill-Fularhat, P.O. &
est Bengal, India. Tel.: þ91
ondal).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).emanate from high-income countries, astringent to 15% of earth's
population. Ten nations vouch for 65% of blood collections world-
wide, and India is the third highest bidder in this respect following
United States and China.2 With almost 9.8 million units of yearly
collections and 84% voluntary donors, India is expected to bang on
the WHO target of 100% voluntary donations by 2020, much before
due date.4
Blood transfusion aggravates the risk of transfusion-
transmissible infections (TTIs) like hepatitis B (HBV), hepatitis C
(HCV), Human Immunodeﬁciency Virus (HIV), syphilis, and less
commonly to malaria, toxoplasmosis, brucellosis, other viral in-
fections.5 As of 2009, around 2.5 million Indians were infected with
HIV. Succumbing to a prevalence of 0.3%, India presently stands
third on planet, in numerical terms of HIV-infected people.6 How-
ever its prevalence among subcontinental donors ﬂuctuates
through literatures, from 0.02 to 8.5%.7
Globally, HBsAg (Hepatitis B surface antigen) prevalence varies
between 0.1 and 11.7%.7 Amongst Indian general population andrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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Universally around 3% people are infected with HCV.11 Accord-
ingly, worldwide 0.4e19.2% blood donors test positively for HCV. In
contrast, a low cumulative HCV prevalence below 2% has been re-
ported from this country.9,10,1214
Darjeeling district in India, has a high HIV prevalence of >1%,
much higher than national distribution.15 Despite that, very little is
learnt about the seroprevalence of HIV and other TTIs among blood
donors here. The present study accomplished at the lone tertiary
medical institution in rural sub-Himalayan belt of Darjeeling, West
Bengal, India; was aimed at recollecting the donors' proﬁle,
particularly emphasizing the seroprevalence of TTIs amongst themFig. 1. Age and sex distribution of bloodand determination of the suitable population-module to be tar-
geted for upscaling the voluntary blood donors' strength. Conse-
quently, the overall knowledge about blood safety measurements
and a rough estimate of the infection burden in rural community
can be replenished.
2. Materials and methods
The presently discussed, institutional record-based retrospec-
tive study was executed in the Department of Blood bank, North
Bengal Medical College & Hospital, Darjeeling, West Bengal, India.
Data from three consecutive years of 2010e2012, was retrieveddonors in three years (2010e12).
Fig. 2. Correlation of blood donation camps with types of donation.
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Hospital-based replacement donors alongside blood camp-based
voluntary donors were tabulated. All these data was analysed by
utilizing descriptive statistics included in SPSS version 16.0. Various
immunological screening methods were performed on all donated
samples for HIV-1 & 2, HBsAg, HCV (by enzyme-linked immuno-
sorbent assay or ELISA), syphilis (by Venereal Disease Reference
Laboratory or VDRL rapid card test from Transasia Biomedicals
Limited) and malaria (by SD BIOLINE Malaria Antigen P.f./P.v. rapid
diagnostic card test or RDT for pan-malarial antigens). Recom-
mended donor exclusion criteria were: history of febrile or debili-
tating illness, weight loss, jaundice, hepatic or cardiovascular or
pulmonary derangement, malignancy, epilepsy, bleeding diathesis,
past blood transfusion, recent blood donation, consumption of
prohibited drugs, surgical intervention, age under 18 or over 60
years, pregnancy or lactation.Table 1
Prevalence of TTIs among blood donors.
Diseases Years Total
(N ¼ 28,364)
p-value
2010
(N ¼ 8392)
2011
(N ¼ 9552)
2012
(N ¼ 10,420)
HIV 36 (0.43%) 42 (0.44%) 40 (0.38%) 118 (0.42%) 0.8446
HBsAg 112 (1.33%) 138 (1.44%) 103 (0.99%) 353 (1.24%) 0.0126*
HCV 43 (0.51%) 57 (0.6%) 75 (0.72%) 175 (0.62%) 0.1724
VDRL 95 (1.13%) 40 (0.42%) 50 (0.48%) 185 (0.65%) <0.0001*
MP 00 00 1 (0.01%) 1 (0.004%) 0.4268
Total 286 (3.41%) 277 (2.90%) 269 (2.58%) 832 (2.93%) 0.0041*
* Statistically signiﬁcant p-values.
HIV: Human immunodeﬁciency virus; HBsAg: Hepatitis B surface antigen; HCV:
Hepatitis C Virus; VDRL: Venereal disease research laboratory; MP: Malarial
parasites.3. Results
Total 28,364 donors were screened during the period of January
2010 to December 2012. Most of the donors were aged 35 years or
less, and a mere 4.27% (1210) donors were living beyond their mid-
forties. Males were the dominant cohort, while females constituted
only 10.04% (2847) of the study population (Fig. 1). A sum of 476
blood donation camps were arranged, which collectively compiled
20,985 (73.98%) voluntary donations. Astonishingly, the voluntary
donors' strength drastically declined in 2012 than its yesteryears,
which actually reﬂected the reduction in donation camps instituted
that year, with profound statistical signiﬁcance (p < 0.0001) (Fig. 2).
As a whole 832 seropositive donors were identiﬁed corre-
sponding to a summed-up seroprevalence of 2.93%. However, a
statistically signiﬁcant (p ¼ 0.0041) downgrading trend in overall
seroprevalence of TTIs, was elicited over observed three years.
Seroprevalence of HIV, HBV, HCV and syphilis among studied do-
nors were 0.42%, 1.24%, 0.62% and 0.65% respectively. More
importantly, a downscaling tendency in seroprevalence of HBV(p¼ 0.0126) and syphilis (p < 0.0001), over the projected years was
again derived with noteworthy statistical signiﬁcance. In the ﬁnal
year, the only case of vivax malaria was encountered in a male
voluntary donor (Table 1). None of the seropositive donors were co-
infected with any additional TTI.
Apart from HCV (p ¼ 0.0256) no signiﬁcant difference between
two principle donor categories could be deducted from their
respective individual susceptibility to any other TTI. In addition, the
overall seroprevalence of TTIs was signiﬁcantly (p ¼ 0.0398) more
pronounced amongst replacement donors (3.28%) than their
voluntary (2.81%) counterparts (Table 2).
Altogether the highest prevalence for each TTI was observed in
the 26e35 years age group, followed by the 36e45 years age group.
Seropositivity among discussed donors dipped lowest for the >45
years age group. Age variation of seroprevalence was statistically
signiﬁcant with the likes of HBV, HCV and syphilis particularly
during the years of 2010e11, 2011e12 and 2012 respectively
(Table 3). Gender-wise difference in seroprevalence with HBsAg
(p ¼ 0.0064) and VDRL (Venereal disease research laboratory test)
(p < 0.0001) also attained statistical signiﬁcance in this presently
concluded study (Fig. 3).
Table 2
Distribution of TTIs among blood donors according to their type of donation.
Diseases Types of blood donation Total
(N ¼ 28,364)
p-value
Voluntary
(N ¼ 20,985)
Replacement
(N ¼ 7379)
HIV 87 (0.41%) 31 (0.42%) 118 (0.42%) 1.000
HBsAg 255 (1.22%) 98 (1.33%) 353 (1.24%) 0.4669
HCV 116 (0.55%) 59 (0.80%) 175 (0.62%) 0.0256*
VDRL 131 (0.62%) 54 (0.73%) 185 (0.65%) 0.3142
MP 1 (0.005%) 00 1 (0.004%) 0.5431
Total 590 (2.81%) 242 (3.28%) 832 (2.93%) 0.0398*
* Statistically signiﬁcant p-values.
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Blood transfusion is a life-saving integral remedy in current
medical practices, but also carries contemporary risk of trans-
mitting dreadful TTIs like HIV, hepatitis B and C.16 Distressed with
this disquiet fact, WHO indoctrinated a detailed strategy in trans-
fusion protocol which potentiates well-orchestration of transfusion
services, promotion of voluntary donation with uttermost priority,
effective exemption of all seropositive samples particularly those
with the four commonest TTIs, and establishment of an implicit
quality control system.7
The overall seroprevalence of various TTIs among the studied
donors ﬁgured out as 2.93% with a signiﬁcant dwindling trend over
successive years, which intimately stimulated previous observa-
tions by Mathai et al17 (3.1%), Karmakar et al18 (2.79%) and Koshy
et al7 (2.9%). However, contrasting evidences of signiﬁcantly lower
or higher seropositivity under subcontinental circumstances also
prevails at large.1922
The infectivity of HBV, HCV, HIV and syphilis amongst Indian
donors has been documented as 0.66e12%, 0.5e1.5%, 0.084e3.87%
and 0.85e3% respectively.23 HBV was the most frequent (1.24%) TTI
encountered in presently concluded study, recapitulating earlier
Indian literatures accomplished in similar context.7,16,18,20,23 On the
other hand, Garg et al13 and Sinha et al22 reiterated much higher
proportion of HBsAg seropositivity; as well as a lower seropreva-
lence reported by Adhikari et al19 and Unnikrishnan et al21, con-
tradicts the current elaboration.
Moreover, Mathai et al17, Gupta et al8 and Koshy et al7
encountered anti-HCV seroreactivity as the commonest TTI in
their respective studies. On the contrary, around 0.62% subjects
were tested reactive for anti-HCV antibody within the discussedTable 3
Age distribution of TTIs among blood donors.
Diseases Age groups
18e25 yrs 26e35 yrs 36e45 y
2010 (N ¼ 8392)
HIV 6 (0.07%) 16 (0.19%) 13 (0.15%
HBsAg 26 (0.31%) 48 (0.57%) 28 (0.33%
HCV 11 (0.13%) 17 (0.20%) 12 (0.14%
VDRL 25 (0.30%) 41 (0.49%) 22 (0.26%
2011 (N ¼ 9552)
HIV 11 (0.12%) 18 (0.19%) 11 (0.12%
HBsAg 31 (0.32%) 57 (0.60%) 38 (0.40%
HCV 13 (0.14%) 19 (0.20%) 22 (0.23%
VDRL 9 (0.09%) 18 (0.19%) 12 (0.13%
2012 (N ¼ 10,420)
HIV 8 (0.08%) 18 (0.17%) 11 (0.11%
HBsAg 27 (0.26%) 44 (0.42%) 25 (0.24%
HCV 17 (0.16%) 32 (0.31%) 21 (0.20%
VDRL 9 (0.09%) 19 (0.18%) 18 (0.17%
* Statistically signiﬁcant p-values.donor population, which lagged third behind hepatitis B and
syphilis in the list of TTIs. Chattoraj et al23 also experienced iden-
tical order of seropredominance among their examined donors.
Pertinent to present discussion, Giri et al16 and Karmakar et al18
identiﬁed 0.74% and 0.59% HCV-positive donors respectively;
though opposing views are also quite obvious.1922
Serological evidences for syphilis turned out to be afﬁrmative in
0.65% of currently studied donations, which also featured a signif-
icantly progressive diminution over the years. Most of the previ-
ously published Indian literatures recorded amuch lower incidence
of VDRL reactivity.13,16,18,24 But yet Gupta et al encountered about
0.85% syphilis patients in their observed group.8
Although HIV-prevalence in Darjeeling district (1%) is much
higher than whole Indian (0.3%) scenario;15 still HIV-
seroprevalence in discussed donors was quantiﬁed as 0.42% only,
least of the chief four TTIs and more comparable to national sero-
prevalence. Garg et al13 (0.47%), Kaur et al20 (0.6%), Sinha et al22
(0.64%) and Karmakar et al18 (0.6%) traced HIV-seropositivity to
similar extent of present study; whereas Gupta et al8 (0.08%),
Agrawal et al24 (0.1%) and Giri et al16 (0.07%) identiﬁed much less
number of HIV-infected donors.
According to National AIDS Control Organization (NACO)
guidelines, donors affected with malaria should be temporarily
deferred for next three months.18 The lone malaria-infested donor
was detected in the ﬁnal year of present study. Dubey et al suc-
cessfully detected 0.09% malaria-infected donors using RDT, while
the prevalence ﬂourished as high as 17.4% with serological assay for
malarial antibody.25 RDT is associated with high sensitivity and it
promptly turns negative 2e3 days after effective eradication of
parasites, in contrast the antibody against Plasmodia persists for
days after successful therapy.26 Likewise, the donors in the present
study were efﬁcaciously screened out for malaria using RDT.
In this on-going study most of the donors were males, which
beautifully coincided with preceding Indian observations. Despite
the overall seroprevalence hardly differed between genders, the
seroreactivity for HBsAg and VDRL was found to be signiﬁcantly
higher among males, which is at par with already recommended
articles.16 Such gender variation in seroresponsiveness could be
attributed to their heterogeneous risk-behaviour.
Koshy et al notedmost of their studied seropositive donors to be
aged between 18 and 30 years, followed by 31e40 years.7 More
than two-third seropositive donors belonged to 21e40 years age
group in the study conducted by Karmakar et al.18 Accordingly,
most of the infected donors in present study were from 26 to 35Total p-value
rs >45 yrs
) 1 (0.01%) 36 (0.43%) 0.0664
) 10 (0.12%) 112 (1.33%) 0.0020*
) 3 (0.04%) 43 (0.51%) 0.4634
) 7 (0.08%) 95 (1.13%) 0.1463
) 2 (0.02%) 42 (0.44%) 0.2790
) 12 (0.13%) 138 (1.44%) <0.0001*
) 3 (0.03%) 57 (0.60%) 0.0011*
) 1 (0.01%) 40 (0.42%) 0.1292
) 3 (0.03%) 40 (0.38%) 0.0978
) 7 (0.07%) 103 (0.99%) 0.1069
) 5 (0.05%) 75 (0.72%) 0.0257*
) 4 (0.04%) 50 (0.48%) 0.0010*
Fig. 3. Sex distribution of TTIs among blood donors.
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syphilis were more prevalent among 26e45 years aged donors
yielding distinct statistical signiﬁcance.
In the earlier studies, replacement donors frequently out-
numbered the voluntary ones.13 Whatsoever in correspondence
to existing worldwide trend, voluntary donors were profusely
predominant in discussed study population. The overall sero-
dominance among voluntary donors was overwhelmed by that
of replacement donors, conquering a statistically signiﬁcant
difference. This above-mentioned difference in present study
reciprocated the results obtained by Kaur et al27 and Koshy
et al.75. Conclusion
In conclusion, the latest study highlights that blood transfusion
is one of the major modes to contact HIV, HBV, HCV and syphilis.
Males as much as the voluntary donors overwhelmingly predom-
inate the donor subpopulation in modern world. The voluntary
donor strength intimately correlates with the number of blood
camps. HBV is the most and HIV the least common TTI affecting
blood donors, with a signiﬁcant downhill tendency in overall
seroprevalence through the years. Donors aged between 26 and 35
years are signiﬁcantly associated with TTIs as good as the
replacement donors do. Therefore some immaculate eligibility
R. Mandal, K. Mondal / Journal of Traditional and Complementary Medicine 6 (2016) 224e229 229criteria should be adopted while selecting blood donors to mini-
mize the transmission of potentially fatal infections, to augment the
pool of voluntary donors and to increase the feminine participation
in nationalized donation campaigns.
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